Original language | English |
---|---|
Pages (from-to) | 338 - 341 |
Number of pages | 4 |
Journal | American Journal of Clinical Oncology |
Volume | 32 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2009 |
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer (CRPC).
Carmel Pezaro, Mark Rosenthal, Howard Gurney, Ian Davis, Craig R Underhill, Michael J Boyer, Dusan Kotasek, Benjamin Solomon, Guy Toner
Research output: Contribution to journal › Article › Research › peer-review
43
Citations
(Scopus)